Form 10-Q · Quarterly report
Align Technology 10-Q, filed Nov 4, 2026
- Filed
- CIK
- 0001097149
- Accession no.
- 0001097149-26-000081
Summary
Align Technology reported third-quarter 2026 revenues of $1,015 million, up 1.9% year-over-year, alongside a restructuring plan expected to cost $35–37 million and a $43.1 million estimated UK VAT liability after the Upper Tribunal ruled clear aligners are not dental prostheses and are taxable at the standard rate, a decision Align intends to appeal. The company also announced plans for a first manufacturing facility in India, in Hyderabad, expected to start operations in 2027 with about $200 million of investment.
Key points
- Align Technology reported third-quarter 2026 revenues of $1,015 million, up 1.9% year-over-year, with net income of $135 million ($1.90 diluted per share) and operating margin of 16.7%.
- A 2026 restructuring plan cutting the global workforce is expected to cost $35.0–$37.0 million, of which $28.5 million was incurred as of September 30, 2026.
- Align plans a new manufacturing facility in Hyderabad, India — its first in the country — expected to begin operations in 2027 with roughly $200 million of investment over several years.
- Align recorded a $43.1 million estimated UK VAT liability after the Upper Tribunal (Tax and Chancery Chamber) held clear aligners are not dental prostheses and are subject to standard-rate VAT; the company intends to appeal.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management’s Discussion Recent Developments New Manufacturing Facility: During the second quarter, we announced plans to expand our global manufacturing network with a new facility in Hyderabad, India, which is expected to commence operations in 2027 and will represent our first manufacturing facility in India. We expect to invest approximately $200 million over the next several years in connection with the project, including both capital expenditures and operating costs. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.